Oligonucleotide Drug Delivery Is Moving Beyond the Liver
San Diego, CA, Sept. 03, 2026 (GLOBE NEWSWIRE) -- For oligonucleotide medicines, precise delivery remains one of the field’s most important priorities. The liver has become an established target for systemic delivery, with GalNAc conjugation providing a clinically validated route into hepatocytes…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.